Blogs | Multibagger Shares

April 24, 2026

Horizontal Bar Chart of Working Capital Days Cash Conversion by Fiscal Year from Fy20 to Fy25 with Values Fy20 28 Fy21 26 Fy22 22 Fy23 18 Fy24 14 Fy25 11 Fy25 Bar is Green

Working Capital Days & Cash Conversion Cycle

Decode Cash Conversion Cycle and Working Capital Days the way serious value investors do — and see how Titan Biotech's 261-day FY25 CCC is fully self-funded with near-zero debt.

April 24, 2026

Hero Banner with Title the Fat Pitch Principle and Green Subtitle Below is a Four block Grid Labeled Trader gray Compounder green Drift light Gray Speculator orange

The Fat Pitch Principle: Warren Buffett’s Ted-Williams-Inspired Rule for Swing Selectivity in Indian Value Investing

Why the 77-cell strike zone Ted Williams built and Warren Buffett later adapted remains the single most decision-disciplining mental model for Indian value investors — illustrated with Titan Biotech's FY25 numbers.

April 23, 2026

Hero Section with a Dark Navy Background Showing a Capacity Utilisation Bar Chart from Fy20 to Fy25 Ending at 11 for Fy25 green Bar the Page Title is capacity Utilisation with a Subtitle About Growth

Capacity Utilisation: When Existing Plants Can Fund the Next Leg of Growth

Capacity Utilisation becomes more useful when investors translate it into audited numbers, cleaner disclosure, and better minority-shareholder readability.

April 23, 2026

Hero Header for base Rate Neglect Article with a 2x2 Color Grid Labels Lucky Disciplined Investor Confused and Bias trapped Conveying Investor Mindsets

Base Rate Neglect: The Kahneman-Tversky 1973 Cognitive Bias Behind ₹1.8 Lakh Crore of Indian F&O Losses

Kahneman & Tversky's 1973 "Tom W." experiment exposed base rate neglect — the bias behind 93% Indian F&O loss rates. Learn the 5-step counter-measure framework, and see how Titan Biotech's FY25 CFO/OP of 103%, ₹3 Cr borrowings, and 29% 10-year profit CAGR illustrate favourable-tail corporate markers (educational case study, not a valuation call).